M. Docteur Frédéric LAVIE
Diplômes
🎓 DES & spécialité ordinale
- DES Rhumatologie
- Rhumatologie (SM)
🎓 Diplômes
- DE Docteur en médecine
Source : Annuaire Santé ANS (FHIR Practitioner.qualification) · Mises à jour quotidiennes.
Thèses universitaires
Source : catalogue national des thèses theses.fr (ABES). Ne couvre que les doctorats / HDR — les thèses d'exercice (DES) sont archivées dans les SCD universitaires.
Bibliographie
Guselkumab Improves Patient-Reported Outcomes Among Participants With Psoriatic Arthritis and Inadequate Response to Tumour Necrosis Factor Inhibitors in the COSMOS Study
2026ArticleRheumatology and Therapy
Patient Profiles in Randomized Controlled Trials Versus a Real-World Study in Psoriatic Arthritis: Scoping Review and Metaanalysis
2025ArticleJournal of Rheumatology
Multi-domain effectiveness of guselkumab evaluated via composite indices through 1 year in patients with PsA and inadequate response to TNFi: post hoc analysis of COSMOS
2024ArticleRheumatology
Response to treatment in psoriatic arthritis, the effect of age: analysis of patients receiving ustekinumab in the PsABio real-world study
2023ArticleArthritis Research & Therapy
Improvement in patient-reported outcomes and work productivity following 3-year ustekinumab or tumour necrosis factor inhibitor treatment in patients with psoriatic arthritis: results from the PsABio real-world study
2023ArticleArthritis Research & Therapy
Gender-specific differences in patients with psoriatic arthritis receiving ustekinumab or tumour necrosis factor inhibitor: real-world data
2023ArticleRheumatology
Long-term effectiveness and persistence of ustekinumab and TNF inhibitors in patients with psoriatic arthritis: final 3-year results from the PsABio real-world study
2022ArticleAnnals of the Rheumatic Diseases
Treat to target versus standard of care for patients with Crohn's disease treated with ustekinumab (STARDUST): an open-label, multicentre, randomised phase 3b trial
2022ArticleThe Lancet Gastroenterology & Hepatology
Source : HAL — archive ouverte CCSD/CNRS (couvre articles, chapitres EMC, communications congrès, thèses).
Localisation des cabinets
Adresses géocodées via la Base Adresse Nationale (api-adresse.data.gouv.fr). Précision indicative.
Lieux de consultation
CABINET DU DR FREDERIC LAVIE
19 RUE AMPERE, 75017 Paris
Libéral© OpenStreetMapLEEM
LES ENTREPRISES DU MEDICAMENT — 58 BOULEVARD GOUVION SAINT CYR, 75017 Paris
Hospitalier© OpenStreetMapLES ENTREPRISES DU MEDICAMENT
LES ENTREPRISES DU MEDICAMENT 58 BOULEVARD GOUVION SAINT CYR, 75017 PARIS
Activité non soignante
Tarifs & secteur de conventionnement
Prendre rendez-vous & contact
Lien Doctolib = recherche Google site:doctolib.fr (le 1er résultat est presque toujours le profil correct s'il existe).
Publications scientifiques
Aucune publication PubMed identifiée pour ce praticien (recherche par nom — possibles homonymes filtrés).
Datasets & protocoles partagés
Induction of BAFF mRNA by epithelial cells from minor salivary glands
Image2011figshare<b>Copyright information:</b>Taken from "B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome"A
Immunocytochemical analysis of BAFF expression in salivary epithelilal cells from minor salivary glands
Image2011figshare<b>Copyright information:</b>Taken from "B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome"A
Association between BAFF -871 T/C polymorphism and BAFF mRNAin 40 patients with pSS
Image2011Figshare<b>Copyright information:</b>Taken from "No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome"Arthritis Research & Therapy 2006
Association between BAFF -871 T/C polymorphism and BAFF mRNAin 40 patients with pSS
Image2011figshare<b>Copyright information:</b>Taken from "No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome"Arthritis Research & Therapy 2006
Immunocytochemical analysis of salivary epithelial cells
Image2011figshare<b>Copyright information:</b>Taken from "B cell-activating factor of the tumor necrosis factor family (BAFF) is expressed under stimulation by interferon in salivary gland epithelial cells in primary Sjögren's syndrome"A
Association between BAFF -871 T/C polymorphism and serum BAFF level in 95 patients with pSS
Image2011figshare<b>Copyright information:</b>Taken from "No evidence for an association between the -871 T/C promoter polymorphism in the B-cell-activating factor gene and primary Sjögren's syndrome"Arthritis Research & Therapy 2006
Source : DataCite — DOIs pour datasets, logiciels, protocoles, registres patient. Hors articles (déjà couverts).